p16ink4a exerts tumor suppressive function by inhibiting the activities of the cyclin D-dependent kinases, CDK4 and CDK6, and preventing the retinoblastoma protein (Rb) phosphorylation and dissociation from the transcription factor E2F1. Here, CDK6 is linked to neoplasm.